The Future of Cytology (Cytotechnology) Education

 

Bridgette Springer, MBA, CT(ASCP)CM
Program Director
Cleveland Clinic School of Cytotechnology
Cleveland, Ohio

 

Cytology education is evolving. Healthcare advancements have resulted in changing roles for cytologists (cytotechnologists). In order to meet the needs of the future and to align cytology education across programs, cytology education is advancing to a Master’s degree curriculum. This webinar will address changing curriculum needs and will highlight our own program’s journey from a certificate program to a Master’s degree granting program. Common challenges and pitfalls will be discussed.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Summarize the process for moving to a master’s level curriculum in cytology including rationale for the name change for the profession
  • Explain the approval process for a new program both institutionally and in the higher education system
  • Discuss pitfalls and common challenges in implementation of both a new Master’s degree granting program and new entry level competencies
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 Participant
Course opens: 
08/22/2023
Course expires: 
08/21/2026
Cost:
$105.00

Presenter(s):
Bridgette Springer, MBA, CT(ASCP)CM

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:
Oscar Lin MD PhD: Consultant – Hologic and Jansen
Liron Pantanowitz MD: Consultant – Hamamatsu, Advisory Board for Ibex
Martha B Pitman MD FIAC: Consultant – Adenocyte, LLC
Donna K. Russell MEd CT(ASCP) HT(ASCP): Advisory Board – Hologic Scientific
Christopher J. VandenBussche MD PhD: Ad hoc advisory board panel and Consultant – Roche

The following individuals have reported no relevant financial relationships:
Susan A. Alperstein, MS, CT(ASCP), Donna Armyalagos, BA, CT(ASCP), Cheryl K. Arnott, SCT(ASCP), Kristen A. Atkins, MD, Khalid Amin, MD, Guliz A. Barkan, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Bonnie Choy, MD, Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Kara L. Hansing, MEd, SCT(ASCP)CM, Elizabeth M. Jacobi, MD, Jennifer B. Kernodle-Zimmer, BS, SCT(ASCP), Sara E. Monaco, MD, Caleigh-Shea Murphy, Gabriela M. Oprea-Ilies, MD, Maria Luisa C. Policarpio-Nicolas, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin T. Siddiqui, MD, FIAC, Jose Victor Scarpa Carniello, MD, Sheila Segura, MD, Paul N. Staats, MD

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.

Presenter:
The presenter has no conflicts of interest or financial relationships to disclose.

ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Continuing Certification (CC)
This product can help fulfill the CME requirements mandated by the American Board of Pathology Continuing Certification (CC) process.  Earn up to 2.0 Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 Participant

Price

Cost:
$105.00
Please login or register to take this course.